Latest Trading on NASDAQ

$2.89
0.34%
(-0.01)
Open 2.90
Previous Close 2.90
Today's Range
2.84 2.92
52 Week Range
0.68 6.07
Volume 610.50K
Avg. Volume (Weekly) 776.74K
Bid 2.91
Ask 2.94
Market Cap 471.93K
EPS -0.14
Shares Outstanding 162.74K
YTD High 6.07
Updated September 14, 2021

22nd Century Group, Inc.

22nd Century Group Inc. (“XXII”), based in Williamsville, New York, is a biotechnology company that genetically engineers tobacco, hemp, and cannabis plants. Through their R&D efforts, they develop strains of plants that vary in the levels of active compounds produced by the plants or strains of plants tailored to thrive in specific, and even extreme, conditions.  They both license and manufacture the technology that results from their R&D and also provide contract manufacturing for other companies’ branded-tobacco products.

No data to display.

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company’s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.